References
- Smolen J. S., Aletaha D., Machold K. P. Therapeutic strategies in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2005; 19: 163–77
- Lard L. R., Visser H., Speyer I., van der Horst‐Bruinsma I. E., Zwinderman A. H., Breedveld F. C., et al. Early versus delayed treatment in patients with recent‐onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 2001; 111: 446–51
- Makinen H., Kautiainen H., Hannonen P., Mottonen T., Leirisalo‐Repo M., Laasonen L., et al. Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis. J Rheumatol 2007; 34: 316–21
- Verschueren P., Esselens G., Westhovens R. Daily practice effectiveness of a step‐down treatment in comparison with a tight step‐up for early rheumatoid arthritis. Rheumatology (Oxford) 2008; 47: 59–64
- Aletaha D., Funovits J., Keystone E. C., Smolen J. S. Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients. Arthritis Rheum 2007; 56: 3226–35
- van der Kooij S. M., Goekoop‐Ruiterman Y. P., Vries‐Bouwstra J. K., Peeters A. J., van Krugten M. V., Breedveld F. C., et al. Probability of continued low disease activity in patients with recent onset rheumatoid arthritis treated according to the Disease Activity Score. Ann Rheum Dis 2008; 66: 266–9
- Mottonen T., Hannonen P., Korpela M., Nissila M., Kautiainen H., Ilonen J., et al. Delay to institution of therapy and induction of remission using single‐drug or combination‐disease‐modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum 2002; 46: 894–8
- Drossaers‐Bakker K. W., de Buck M., van Zeben D., Zwinderman A. H., Breedveld F. C., Hazes J. M. Long‐term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time. Arthritis Rheum 1999; 42: 1854–60
- Welsing P. M., van Gestel A. M., Swinkels H. L., Kiemeney L. A., van Riel P. L. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum 2001; 44: 2009–17
- Aletaha D., Smolen J., Ward M. M. Measuring function in rheumatoid arthritis: identifying reversible and irreversible components. Arthritis Rheum 2006; 54: 2784–92
- Young A., Dixey J., Cox N., Davies P., Devlin J., Emery P., et al. How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow‐up in 732 patients from the Early RA Study (ERAS). Rheumatology (Oxford) 2000; 39: 603–11
- de Croon E. M., Sluiter J. K., Nijssen T. F., Dijkmans B. A., Lankhorst G. J., Frings‐Dresen M. H. Predictive factors of work disability in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2004; 63: 1362–7
- Puolakka K., Kautiainen H., Mottonen T., Hannonen P., Hakala M., Korpela M., et al. Predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up study. Ann Rheum Dis 2005; 64: 130–3
- Burton W., Morrison A., Maclean R., Ruderman E. Systematic review of studies of productivity loss due to rheumatoid arthritis. Occup Med (Lond) 2006; 56: 18–27
- Puolakka K., Kautiainen H., Mottonen T., Hannonen P., Korpela M., Hakala M., et al. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent‐onset rheumatoid arthritis: five‐year experience from the FIN‐RACo trial. Arthritis Rheum 2005; 52: 36–41
- Wolfe F., Hawley D. J. The longterm outcomes of rheumatoid arthritis: work disability: a prospective 18 year study of 823 patients. J Rheumatol 1998; 25: 2108–17